Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine-assisted Therapy for Advanced GI Cancer
Brian Anderson, MD
Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
University of Utah
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
GH Research Ireland Limited
Phase 2 Clinical Trial of GH001 in Postpartum Depression
GH Research Ireland Limited
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
National Institute of Mental Health (NIMH)
Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression
Zylorion Health
Ketamine Pilot Study
Meghan Spyres
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics
University of British Columbia
Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED
University of Aarhus
The Using Postoperative Ketamine and Exploring the Effect on Endometriosis Pain (UPKEEEP) Study
NYU Langone Health
Ketamine for OUD and Comorbid Depression (OUDCD)
University of Maryland, Baltimore
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
Yale University
KAP for Depression in Abstinent Opioid Users
Medical University of South Carolina
Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
Entheon Biomedical Corp.
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Resilient Pharmaceuticals
Vital Capacity in Ultrasound Guided Serratus Plane Block in ED Patients With Multiple Rib Fractures
Antonios Likourezos
Visual Surround Suppression and Perceptual Expectation Under Psilocybin
University of Minnesota
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Beckley Psytech Limited
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study
Biogen
Ketamine in Veterans With Gulf War Illness
Baylor College of Medicine
The Effects of Low Dose Ketamine on Cardiovascular Function
University of Texas Southwestern Medical Center
ESKETamine for FIBromyalgia Treatment
Grand Hôpital de Charleroi
AnaConDa-therapy in COVID-19 Patients
Jeroen Bosch Ziekenhuis
PVB vs Ketamine/Lidocaine in Rib Fracture Patients
George Washington University
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Usona Institute
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
Corewell Health East
Prophylactic Effects of Psilocybin on Chronic Cluster Headache
Gitte Moos Knudsen
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Naval Medical Center Camp Lejeune
Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer
Kantonsspital Winterthur KSW
Ketamine Interleaved With Electroconvulsive Therapy for Depression
St Patrick's Hospital, Ireland
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
Rebecca Price
Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED
Abigail Nixon
Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery
Jacques E. Chelly
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
Mercy Health Ohio
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
University of Alabama at Birmingham
Avoiding Neuromuscular Blockers to Reduce Complications
Beth Israel Deaconess Medical Center
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
Yale University
The Role of HNKs in the Antidepressant Effect of Ketamine
Columbia University
Ketamine for Pain in the Emergency Department
Hackensack Meridian Health
Effects of Psilocybin in Concussion Headache
Yale University
Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
The University of Texas Health Science Center, Houston
Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis
Jeffrey Gelfand
Acute Pain Management in Patients on Opioid Replacement Therapy
University of California, San Francisco
IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair
Corewell Health East
Paravertebral Nerve Blocks in Neonates
Emory University
Ketamine in Borderline Personality Disorder
Yale University
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
Johns Hopkins University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.